关键数据
17.200今开
18.070最高
9.03K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.03%换手率
16.590昨收
15.920最低
156.77K成交额
亏损市盈率静
-17.78市净率
0.00%股息率 TTM
-74.88%ROA
18.07052周最高
0.10量比
-61.84M净利润
30.93M总股本
-1.5635每股收益TTM
1.88Beta
-1746.27%ROE
3.22052周最低
12.96%振幅
84.02%毛利率
551.79M总市值
11.20回报/风险
5.99%风险率

即将为您带来更多新闻,敬请期待。。。
AVITA Medical Inc评分
0.21与上次评分对比预测7.00
财务诊断7.84
技术分析5.32
公司估值9.37
机构认同度3.00
风险评估4.63
分析师评级
买入评级
13.667目标均价
-12.67%涨幅空间
AVITA Medical Inc 最新财报电话会记录
AVITA Medical (RCEL) 2026年第三季度业绩电话会:营收增长53%上调业绩指引
AVITA Medical在2026年第三季度财报电话会议上公布了53%的营收增长、84%的毛利率以及现金消耗的减少,并将2026年营收指引上调至9200万至9400万美元。
财务指标
货币: USD

由于公司未披露,未能获取相关数据
货币: USD

由于公司未披露,未能获取相关数据
AVITA Medical Inc 简介
AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.
行业生物技术与医疗研究
公司代码RCEL
员工数量260
国家United States of America
持股情况
| 持股股东 | 占比 |
|---|
| Vanguard Capital Management, LLC | 4.34% |
|---|
| BlackRock Institutional Trust Company, N.A. | 3.28% |
|---|
| Geode Capital Management, L.L.C. | 1.56% |
|---|
| State Street Investment Management (US) | 1.36% |
|---|
| 股东类型 | 占比 |
|---|
| Investment Advisor | 10.66% |
|---|
| Investment Advisor/Hedge Fund | 4.72% |
|---|
| Individual Investor | 0.96% |
|---|
| Research Firm | 0.60% |
|---|
常见问题
AVITA Medical Inc(RCEL)的当前股价是多少?
AVITA Medical Inc(RCEL)的当前股价是 16.59。
AVITA Medical Inc的股票代码是什么?
AVITA Medical Inc的股票代码是RCEL。
AVITA Medical Inc股票的52周最高点是多少?
AVITA Medical Inc股票的52周最高点是18.07。
AVITA Medical Inc股票的52周最低点是多少?
AVITA Medical Inc股票的52周最低点是3.22。
AVITA Medical Inc的市值是多少?
AVITA Medical Inc的市值是513.13M。
现在AVITA Medical Inc(RCEL)的股票是买入、持有还是卖出?
根据分析师评级,AVITA Medical Inc(RCEL)的总体评级为买入,目标价格为13.67。
AVITA Medical Inc(RCEL)股票的每股收益(EPS TTM)是多少
AVITA Medical Inc(RCEL)股票的每股收益(EPS TTM)是-1.56。